Abstract
Primary cutaneous B-cell lymphoma (PCBCL) is a rare group of clonal B-cell lymphoproliferative disorders present in the skin. Two indolent forms of PCBCL are primary cutaneous follicle center lymphoma (PCFCL), and marginal zone B-cell lymphoma (PCMZL). The primary aim of this study was to analyze the outcomes of patients with PCBCL treated with intralesional rituximab. A retrospective search of patients with PCBCL treated with intralesional rituximab was performed across the Mayo Clinic enterprise.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
